ReviewJournal of research in medical sciences : the official journal of Isfahan University of Medical Sciences2025
Status and outlook of pulmonary tuberculosis coinfection.
Review in Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Post-Tuberculosis Lung Disease: Clinicopathologic Insights, Diagnosis, Prevention, and Management.MedComm · 2026Review
- Methicillin and inducible clindamycin resistance in Gram-positive cocci among GeneXpert-positive pulmonary tuberculosis patients and apparently healthy individuals in Northwest Ethiopia.BMC microbiology · 2026Article
- Molecular signaling in coinfection: howFrontiers in immunology · 2026Review
- The diagnostic value of targeted next-generation sequencing for smear-negative and sputum-scarce pulmonary tuberculosis.American journal of translational research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Coinfections with pulmonary tuberculosis (TB) occur in people with damaged lung structures, chronic malnutrition, and those with compromised immunity. Moreover, it is a common clinical challenge that leads to poor clinical outcomes and contributes to increased morbidity and mortality in patients with TB. Coinfection in the lungs can prolong hospital stay and increase the cost of treatment for TB patients, which imposes a heavy burden on families and society. Therefore, pulmonary TB (PTB) combined with pulmonary infections should be diagnosed and treated promptly. This review describes trends in epidemiology and other factors that influence the incidence of PTB coinfection. Current and emerging diagnoses well as infection treatments are discussed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.